[HTML][HTML] Recent advances in functionalized nanoparticles in cancer theranostics

S Siddique, JCL Chow - Nanomaterials, 2022 - mdpi.com
Cancer theranostics is the combination of diagnosis and therapeutic approaches for cancer,
which is essential in personalized cancer treatment. The aims of the theranostics application …

Theranostic approaches in nuclear medicine: current status and future prospects

L Filippi, A Chiaravalloti, O Schillaci… - Expert review of …, 2020 - Taylor & Francis
Introduction: Theranostics is an emerging field in which diagnosis and specific targeted
therapy are combined to achieve a personalized treatment approach to the patient. In …

[HTML][HTML] What scans we will read: imaging instrumentation trends in clinical oncology

T Beyer, L Bidaut, J Dickson, M Kachelriess… - Cancer Imaging, 2020 - Springer
Oncological diseases account for a significant portion of the burden on public healthcare
systems with associated costs driven primarily by complex and long-lasting therapies …

[HTML][HTML] Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues

A Nervo, A Ragni, F Retta, M Gallo, A Piovesan… - Journal of …, 2021 - Springer
Bone represents the second most common site of distant metastases in differentiated thyroid
cancer (DTC). The clinical course of DTC patients with bone metastases (BM) is quite …

[HTML][HTML] Recent advances in targeted drug delivery systems for resistant colorectal cancer

M Sharifi-Azad, M Fathi, WC Cho, A Barzegari… - Cancer Cell …, 2022 - Springer
Colorectal cancer (CRC) is one of the deadliest cancers in the world, the incidences and
morality rate are rising and poses an important threat to the public health. It is known that …

Molecular imaging with reporter genes: has its promise been delivered?

I Serganova, RG Blasberg - Journal of Nuclear Medicine, 2019 - Soc Nuclear Med
The first reporter systems were developed in the early 1980s and were based on measuring
the activity of an enzyme—as a surrogate measure of promoter-driven transcriptional activity …

[HTML][HTML] Theranostic nanomedicines for the treatment of cardiovascular and related diseases: current strategies and future perspectives

N Manners, V Priya, AK Mehata, M Rawat, S Mohan… - Pharmaceuticals, 2022 - mdpi.com
Cardiovascular and related diseases (CVRDs) are among the most prevalent chronic
diseases in the 21st century, with a high mortality rate. This review summarizes the various …

[HTML][HTML] Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival

A Jannin, L Lamartina, C Moutarde… - European journal of …, 2022 - Springer
Purpose Bone metastases (BM) from differentiated thyroid carcinoma (DTC) impact
negatively the quality of life and the life expectancy of patients. The aim of the study was (a) …

[HTML][HTML] Current management of bone metastases from differentiated thyroid cancer

S Kato, S Demura, K Shinmura, N Yokogawa… - Cancers, 2021 - mdpi.com
Simple Summary Patients with bone metastases (BMs) from differentiated thyroid carcinoma
(DTC) can live longer than those with BMs from other cancers. BMs from DTC create …

[HTML][HTML] Advances in Antioxidant Applications for Combating 131I Side Effects in Thyroid Cancer Treatment

L Yang, J Ma, P Lei, J Yi, Y Ma, Z Huang, T Wang… - Toxics, 2023 - mdpi.com
Thyroid cancer is the most common endocrine cancer, and its prevalence has been
increasing for decades. Approx. 95% of differentiated thyroid carcinomas are treated using …